Support the development of medical psychedelics for mental health
A project from MIND Foundation in Berlin, Germany
Support us to develop and responsibly destigmatise psychedelics for mental health, well-being and personal growth!
Already 46 donations.
Join in too!
You will receive a donation receipt from betterplace (betterplace.org gGmbH).
About this project
Max de Rosnay from MIND Foundation is responsible for this project
Who we are
The MIND Foundation is a European non-profit organization registered under German law (HRB 220247 B). Since 2017, we have been pioneering the responsible destigmatization of psychedelics, promoting innovative therapies for mental health and human development through leading scientific studies.
Why we exist
Promoting mental health and improving people's well-being are at the centre of MIND's mission.
Around 5 million people suffer from depression in Germany and over 400 million worldwide. Many of them are difficult to treat with current conventional forms of therapy. In the midst of this global mental health crisis, MIND is committed to research and education: We demonstrate the benefits of new psychedelic therapies - both to tackle previously hard-to-treat mental disorders and to improve mental well-being in healthy individuals. We share knowledge, help with the integration of psychedelic experiences and develop the basis for a responsible destigmatisation of psychedelics.
Around 5 million people suffer from depression in Germany and over 400 million worldwide. Many of them are difficult to treat with current conventional forms of therapy. In the midst of this global mental health crisis, MIND is committed to research and education: We demonstrate the benefits of new psychedelic therapies - both to tackle previously hard-to-treat mental disorders and to improve mental well-being in healthy individuals. We share knowledge, help with the integration of psychedelic experiences and develop the basis for a responsible destigmatisation of psychedelics.
Why Your Support Matters
Your donation allows us to continue the following activities at MIND:
- Treatment in the field of mental health: More mental health professionals can be trained through our "Augmented Psychotherapy Training" (APT) programs. We have been educating more than 130 mental health professionals in the last 2 years.
- Leading scientific research projects (with Central Institute of Mental Health in Mannheim and Charité Berlin) can be continued. The EPIsoDE study, in which MIND actively participates, has delivered promising results on the effectiveness of psilocybin in treating depression.
- Responsible destigmatisation of psychedelics: MIND's public outreach can be continued to break down stigma and promote understanding of new and innovative therapeutic approaches. MIND's INSIGHT conference brings together researchers, patients, policymakers, and regulatory institutions to enable an evidence-based implementation of psychedelic therapies.
- Beyond Experience (BE) allows people to "integrate" psychedelic experiences. The main goal of the workshop is to initiate a profound personal integration process that helps participants recall, document, and express their experiences of altered states and to transform these into meaningful and sustainable behavioral changes.
Get informed and get involved
Become a fan and receive news and updates from the organization
Collect donations for this project together with your community
About
betterplace.org is the largest German donation platform. Since 2007 we have been helping people, aid organizations and companies to do good. All projects on betterplace.org are non-profit. Since we ourselves also do not work for profit, our platform is free of charge for the projects.
- 2007founded
- 15,000non-profit organisations
- 300m €for a good cause
